Quvara Medical is a high-performance CMO specialising in autoinjectors, pen injectors, and precision components for pharmaceutical and biotech partners. Our Swindon, UK site manufactures millions of regulated drug-delivery devices for one of the world’s largest medical technology companies and multiple clients every year, and has been delivering repeatable quality at scale for more than 30 years.
Contract manufacturing. Proven experience. Future-ready execution.
Who We Are
30+ years expertise of regulated medical device production.
Quvara Medical integrates proven large-scale production with advanced process control, validated automation, and robust global regulatory compliance.
As a specialist CMO, we enable partners to industrialise drug-device programmes rapidly, secure dual-sourcing resilience, and achieve reliable quality at scale. Our teams provide end-to-end technical support—from tooling and moulding optimisation to process validation, cleanroom assembly, and supply-chain assurance—designed to reduce risk, accelerate launch, and optimise total cost of ownership.
Quality. Validation. Regulatory Approval
What makes us different?
Quvara is not a generic CMO. We are built specifically for regulated, high-volume, repeatable med-tech manufacture, where quality, compliance, and delivery reliability are non-negotiable.
From our Swindon site, we manufacture hundreds of millions of medical devices and components each year, supported by 350 associates, 24/7 operations, and deeply embedded quality systems. Our difference lies not in individual capabilities, but in how they are integrated and scaled.
We focus on:
- Platform-based manufacturing rather than one-off projects
- Embedded validation and regulatory leadership
- Digital, inspection-ready operations
- Long-term partnerships aligned to portfolio growth
Built for regulated scale
Scale without control creates risk. Control without scale creates constraint. Quvara is designed to deliver both.
Our 7,500m² Swindon facility includes 5,500m² of controlled and ISO Class 7 & 8 cleanroom manufacturing space, operating 24/7, 350 days a year. Manufacturing is currently supported by over 50 injection moulding machines incorporating robot part handling, automated and semi-automated assembly lines, in-line inspection, and on-site testing.
This infrastructure enables predictable scale-up, stable yields, and consistent quality output across long product lifecycles — essential for pharma and biotech programmes moving from early commercialisation to sustained global supply.
Platform-first device manufacturing
Quvara specialises in manufacturing platforms, not just products. This approach supports customers managing pipelines, lifecycle extensions, and multi-market strategies.
By designing manufacturing systems that can accommodate controlled variants, we reduce future validation burden, shorten launch timelines, and improve long-term cost efficiency. Platform-first thinking underpins everything from tooling strategies to validation frameworks.
Validation and regulatory leadership
Validation and regulatory compliance are not optional layers at Quvara; they are embedded into how we operate.
Our systems and processes are aligned to ISO 13485:2016, FDA 21 CFR Part 820, ISO 14001, and ISO 45001, supported by electronic batch recording, automated release, and real-time quality trending. This ensures inspection readiness is continuous, not reactive.
Commercially aligned partnership
Quvara works as an extension of our customers’ technical, quality, and operations teams. Our commercial model is designed to support long-term relationships, platform growth, and supply resilience — not transactional manufacturing.
Repeatable quality. Proven scale. Regulatory confidence.
Struggling to find the answer you are looking for?
We have a team of experts ready to help with your queries.
